KLF13 and non-small cell lung carcinoma: Treatment with Exos strikingly raised miR‐3126‐5p expression in NSCLC cells, which was abolished by miR‐3126‐5p inhibitor, but not affected by sh‐KLF13 transfection (Figure S6A).